EP2572717
Lyfjasamsetning sem inniheldur sólífenasín
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
18.5.2011EP published:
15.6.2016EP application number:
11783576.9
EP translation filed:
8.7.2016Grant published:
15.8.2016EPO information:
European Patent Register
Max expiry date:
17.5.2031Expiry date:
17.5.2026Next due date:
31.5.2026
Title:
PHARMACEUTICAL COMPOSITION CONTAINING SOLIFENACIN
Timeline
Today
18.5.2011EP application
15.6.2016EP Publication
8.7.2016Translation submitted
15.8.2016Registration published
17.5.2026Expires
Owner
Name:
Astellas Pharma Inc.Address:
5-11, Nihonbashi-Honcho 2-chome, 103-8411, Chuo-ku, Tokyo, JP
Inventor
Name:
YOSHIOKA TatsunobuAddress:
Tokyo, JP
Name:
MURAI MakotoAddress:
Tokyo, JP
Name:
TASAKI HiroakiAddress:
Tokyo, JP
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
346311 PDate:
19.5.2010Country:
US
Classification
Categories:
A61K 31/4725, A61K 9/10, A61K 47/30, A61K 47/32, A61P 1/00, A61P 11/00, A61P 11/06, A61P 13/00, A61P 13/10, A61P 43/00, A61K 47/48, A61K 31/439
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 10.4.2017
Expires: 17.5.2018
Payer: Árnason Faktor
Number: 8
Paid: 9.4.2018
Expires: 17.5.2019
Payer: Árnason Faktor
Number: 9
Paid: 5.4.2019
Expires: 17.5.2020
Payer: Árnason Faktor
Number: 10
Paid: 7.4.2020
Expires: 17.5.2021
Payer: Árnason Faktor ehf.
Number: 11
Paid: 8.4.2021
Expires: 17.5.2022
Payer: Árnason Faktor ehf.
Number: 12
Paid: 5.4.2022
Expires: 17.5.2023
Payer: Árnason Faktor ehf.
Number: 13
Paid: 23.5.2023
Expires: 17.5.2024
Payer: Árnason Faktor ehf.
Number: 14
Paid: 2.5.2024
Expires: 17.5.2025
Payer: Árnason Faktor ehf.
Number: 15
Paid: 14.5.2025
Expires: 17.5.2026
Payer: Árnason Faktor ehf.